NO995681D0 - Fremgangsmåte for å fremstille fluorbiprofen-tabletter - Google Patents

Fremgangsmåte for å fremstille fluorbiprofen-tabletter

Info

Publication number
NO995681D0
NO995681D0 NO995681A NO995681A NO995681D0 NO 995681 D0 NO995681 D0 NO 995681D0 NO 995681 A NO995681 A NO 995681A NO 995681 A NO995681 A NO 995681A NO 995681 D0 NO995681 D0 NO 995681D0
Authority
NO
Norway
Prior art keywords
fluorobiprofen
tablets
preparing
preparing fluorobiprofen
fluorobiprofen tablets
Prior art date
Application number
NO995681A
Other languages
English (en)
Norwegian (no)
Other versions
NO995681L (no
Inventor
Andrew Day
Huw Lyn Jones
Carl Simon Smith
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO995681D0 publication Critical patent/NO995681D0/no
Publication of NO995681L publication Critical patent/NO995681L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO995681A 1997-05-22 1999-11-19 Fremgangsmåte for å fremstille fluorbiprofen-tabletter NO995681L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process
PCT/EP1998/003167 WO1998052539A1 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Publications (2)

Publication Number Publication Date
NO995681D0 true NO995681D0 (no) 1999-11-19
NO995681L NO995681L (no) 1999-11-19

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995681A NO995681L (no) 1997-05-22 1999-11-19 Fremgangsmåte for å fremstille fluorbiprofen-tabletter

Country Status (31)

Country Link
US (1) US6194003B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0983059B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2001527567A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR20010012739A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1154480C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR015812A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE245021T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU725760B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG103881A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9809651A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2290830C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ290816B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69816440T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0983059T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2202871T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB9710521D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU224954B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ID (1) ID22949A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL132999A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN187837B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY118410A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO995681L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ500664A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL190947B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT983059E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2203046C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK283701B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TR (1) TR199902725T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA53714C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1998052539A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA984260B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4040878B2 (ja) 1999-12-09 2008-01-30 レキット ベンキーザー ヘルスケア （ユーケイ） リミテッド 治療薬
EP1284729A4 (en) * 2000-04-13 2007-12-19 Mayo Foundation REDUCTION AGENTS OF A (BETA) 42
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
CA2532207A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006082501A2 (en) 2005-02-03 2006-08-10 Nycomed Pharma As Fast wet-massing method for the preparation of calcium-containing compositions
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
WO2007014124A2 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
RU2008116871A (ru) * 2005-11-02 2009-12-10 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. (US) Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
CA2680238A1 (en) * 2007-07-23 2009-01-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
WO2010020772A2 (en) * 2008-08-22 2010-02-25 Reckitt Benckiser Healthcare (Uk) Limited Improvements in or relating to compositions
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
CA2860373C (en) 2011-04-29 2017-08-15 Moberg Pharma Ab Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
RU2026670C1 (ru) * 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
IT1243342B (it) 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1244698B (it) * 1991-02-01 1994-08-08 Gentili Ist Spa Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
RU2203046C2 (ru) 2003-04-27
HUP0002121A2 (hu) 2000-12-28
CA2290830C (en) 2006-07-11
DE69816440T2 (de) 2004-05-13
DK0983059T3 (da) 2003-11-03
ES2202871T3 (es) 2004-04-01
NO995681L (no) 1999-11-19
NZ500664A (en) 2001-01-26
PL336624A1 (en) 2000-07-03
TR199902725T2 (xx) 2000-02-21
CZ290816B6 (cs) 2002-10-16
PT983059E (pt) 2003-11-28
DE69816440D1 (de) 2003-08-21
BR9809651A (pt) 2000-07-11
AU725760B2 (en) 2000-10-19
EP0983059A1 (en) 2000-03-08
KR20010012739A (ko) 2001-02-26
PL190947B1 (pl) 2006-02-28
CZ412099A3 (cs) 2000-02-16
IN187837B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2002-06-29
ZA984260B (en) 1999-02-20
MY118410A (en) 2004-10-30
JP2001527567A (ja) 2001-12-25
HU224954B1 (en) 2006-04-28
SK283701B6 (sk) 2003-12-02
US6194003B1 (en) 2001-02-27
EP0983059B1 (en) 2003-07-16
GB9710521D0 (en) 1997-07-16
AR015812A1 (es) 2001-05-30
WO1998052539A1 (en) 1998-11-26
UA53714C2 (uk) 2003-02-17
SK158899A3 (en) 2000-05-16
HUP0002121A3 (en) 2001-04-28
IL132999A0 (en) 2001-03-19
ATE245021T1 (de) 2003-08-15
CN1154480C (zh) 2004-06-23
ID22949A (id) 1999-12-16
AU7916598A (en) 1998-12-11
BG103881A (en) 2000-05-31
CA2290830A1 (en) 1998-11-26
CN1255848A (zh) 2000-06-07

Similar Documents

Publication Publication Date Title
NO995681D0 (no) Fremgangsmåte for å fremstille fluorbiprofen-tabletter
ZA9811630B (en) Process for manufacturing bite-dispersion tablets
FI972727A7 (fi) Menetelmä propeenin kopolymeerien valmistamiseksi
ID21336A (id) Proses untuk pembuatan katalis jenis selubung
ID21160A (id) Proses untuk mempolimerisasi etilena
DK0966287T3 (da) Oxacarbazepinfilmovertrukne tabletter
DK39996A (da) Tøjvasketabletter
ID20274A (id) Proses untuk memproduksi diamina
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
EG22337A (en) Process for preparing novel pharmaceutical compounds
DK0994091T3 (da) Fremgangsmåde til fremstilling methanol
EP1026255A4 (en) PROCESS FOR THE PREPARATION OF XYLITOL
NO20002319D0 (no) FremgangsmÕte for fremstilling av fulven-metallkomplekser
NO20003079D0 (no) Polymerisasjon-oppstartningsprosess
IL134059A0 (en) Process for preparing aminoarylacetylenes
ID18917A (id) Proses untuk sintesis benzotiofena
NO20003080D0 (no) Polymerisasjon-oppstartningsprosess
EG23935A (en) Process for preparing eprosartin
ID20093A (id) Metode untuk memproduksi polibutilena tereptalat
GB9826000D0 (en) Tablets
IL131205A0 (en) Process for preparing pharmaceutical compounds
EP1026254A4 (en) METHOD FOR PRODUCING XYLITOL
EG22077A (en) Process for preparing 4-substituted-ih-indole-3 glyoxamides
FI964410L (fi) Menetelmä 4-amino-delta4-3-ketosteroidien valmistamiseksi 4-nitro-delta4-3-ketosteroidien kautta
ID26021A (id) Proses untuk menyiapan 1h-indole-3-glioksamida disubstitusi-4 1h-indole-glioksamida disubstitusi-4

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application